Fluorine in PDB 7lcr: Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability

Enzymatic activity of Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability

All present enzymatic activity of Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability:
3.4.22.69;

Protein crystallography data

The structure of Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability, PDB code: 7lcr was solved by M.B.Khan, E.Arutyunova, H.S.Young, M.J.Lemieux, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 38.00 / 1.95
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 67.74, 101.51, 102.95, 90, 90, 90
R / Rfree (%) 23.8 / 27.7

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability (pdb code 7lcr). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability, PDB code: 7lcr:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 7lcr

Go back to Fluorine Binding Sites List in 7lcr
Fluorine binding site 1 out of 2 in the Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F401

b:82.4
occ:1.00
 F28 A:XTM401 0.0 82.4 1.0
C27 A:XTM401 1.4 87.6 1.0
C29 A:XTM401 2.3 76.6 1.0
H291 A:XTM401 2.5 91.9 1.0
C26 A:XTM401 2.5 92.6 1.0
H261 A:XTM401 2.7 111.1 1.0
H081 A:XTM401 3.0 69.6 1.0
OD1 A:ASN142 3.0 76.2 1.0
H072 A:XTM401 3.1 64.7 1.0
C08 A:XTM401 3.6 58.0 1.0
C25 A:XTM401 3.7 94.5 1.0
H082 A:XTM401 3.7 69.6 1.0
C23 A:XTM401 3.7 79.8 1.0
HD22 A:ASN142 3.7 100.6 1.0
C07 A:XTM401 3.7 54.0 1.0
CG A:ASN142 4.0 78.2 1.0
H071 A:XTM401 4.1 64.7 1.0
C24 A:XTM401 4.2 90.3 1.0
ND2 A:ASN142 4.2 83.9 1.0
H251 A:XTM401 4.5 113.4 1.0
O01 A:XTM401 4.6 47.6 1.0
O21 A:XTM401 4.9 78.5 1.0
C22 A:XTM401 5.0 77.0 1.0
N09 A:XTM401 5.0 59.5 1.0

Fluorine binding site 2 out of 2 in 7lcr

Go back to Fluorine Binding Sites List in 7lcr
Fluorine binding site 2 out of 2 in the Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure- Activity Studies & Micellar Solubilization For Enhanced Bioavailability within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F401

b:118.8
occ:1.00
 F28 B:XTM401 0.0 118.8 1.0
C27 B:XTM401 1.4 105.1 1.0
C29 B:XTM401 2.3 90.6 1.0
H291 B:XTM401 2.5 108.7 1.0
C26 B:XTM401 2.5 98.6 1.0
H261 B:XTM401 2.7 118.3 1.0
HD22 B:ASN142 2.8 107.7 1.0
H072 B:XTM401 3.3 112.3 1.0
H082 B:XTM401 3.5 85.9 1.0
ND2 B:ASN142 3.6 89.8 1.0
C25 B:XTM401 3.7 94.0 1.0
C23 B:XTM401 3.7 90.0 1.0
H081 B:XTM401 3.8 85.9 1.0
C07 B:XTM401 3.8 93.6 1.0
H071 B:XTM401 3.8 112.3 1.0
C08 B:XTM401 3.9 71.6 1.0
HD21 B:ASN142 4.2 107.7 1.0
OD1 B:ASN142 4.2 82.3 1.0
C24 B:XTM401 4.2 92.8 1.0
CG B:ASN142 4.3 83.3 1.0
H251 B:XTM401 4.5 112.7 1.0
H051 B:XTM401 5.0 71.7 1.0
C22 B:XTM401 5.0 86.9 1.0

Reference:

W.Vuong, C.Fischer, M.B.Khan, M.J.Van Belkum, T.Lamer, K.D.Willoughby, J.Lu, E.Arutyunova, M.A.Joyce, H.A.Saffran, J.A.Shields, H.S.Young, J.A.Nieman, D.L.Tyrrell, M.J.Lemieux, J.C.Vederas. Improved Sars-Cov-2 M Pro Inhibitors Based on Feline Antiviral Drug GC376: Structural Enhancements, Increased Solubility, and Micellar Studies. Eur.J.Med.Chem. V. 222 13584 2021.
ISSN: ISSN 0223-5234
PubMed: 34118724
DOI: 10.1016/J.EJMECH.2021.113584
Page generated: Fri Aug 2 08:51:35 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy